Longitudinal Study of Neurodegenerative Disorders
Launched by UNIVERSITY OF PITTSBURGH · Nov 3, 2017
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the progression of various rare genetic disorders that affect the brain, such as Krabbe Disease and Tay-Sachs Disease, among others. Researchers are collecting and analyzing data to learn how these conditions develop over time and to see how different treatments might help. The study is currently looking for participants of all ages who have a genetic neurodegenerative disorder, with no specific exclusions.
If you or a loved one has been diagnosed with one of these conditions, you may be eligible to participate. By joining this study, participants can help researchers gain valuable insights that could improve future treatments. Those who take part in the trial can expect to provide information about their health and possibly undergo some assessments related to their condition. This is a great opportunity to contribute to a better understanding of these disorders and potentially help others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any patient with a genetic neurodegenerative disorder
- Exclusion Criteria:
- • none
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported